#AI_Pharma
Formation Bio Names Michael Ehlers as New Chief Scientific Officer Driving R&D Strategy#USA#New_York#Formation_Bio#Michael_Ehlers#AI_Pharma
Formation Bio Names Michael Ehlers as New Chief Scientific Officer Driving R&D Strategy
Formation Bio has appointed Michael Ehlers as Chief Scientific Officer to lead R&D efforts. His extensive experience will enhance the company’s drug development capabilities.
third-news.com
July 22, 2026 at 1:09 PM